Keywords
upadacitinib,Rinvoq,Rheumatoid arthritis,active psoriatic arthritis,ankylosing spondylitis,severe atopic dermatitis,inflammatory,crohn's disease,axial spondyloarthritis,ABT-494,janus kinase,inhibitor,enzyme inhibitor,jak inhibition,jak1,jak2,jak3,tyk2,cytokine signalling,immune response,modulation,cell proliferation,cell survival,medication,treatment,pharmacology,ra,psa,as,nr-axspa,uc,cd,aromatic ring,amino pyrimidine,fluorine,amide,skeletal formula,skeletal,notation,carbon,c,oxygen,o,hydrogen,h,single bond,double bond,structural formula,structural,formula,chemical compound,structural chemistry,bond,line bond,charge,stereochemistry,chiral,enantiomer,diastomer,proj-creative-abx-24q2,proj-creative-abx-24q2-AbbVie,rinvoq,Upadacitinib structure